Many notice benefits beyond weight loss, including reduced food cravings, improved cholesterol and blood pressure, better sleep, and relief from conditions like IBS or joint pain
The Trump GLP-1 drug price deal, often referred to as TrumpRx, is a policy initiative designed to establish direct-purchase pricing tiers and negotiated options that lower patient out-of-pocket costs for select anti-obesity medications
They: Increase glucose-dependent insulin secretion Suppress glucagon (a hormone produced by the pancreas that raises blood sugar levels) Slow gastric (stomach) emptying Act on the brain to curb appetite and enhance satiety Common GLP-1s include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and others
These changes often lead to a decrease in the need for additional diabetes medications and a marked improvement in overall health
In fact, the opposite risk is more common